share_log

Needham Maintains Buy on Veracyte, Raises Price Target to $44

Needham Maintains Buy on Veracyte, Raises Price Target to $44

Needham維持對veracyte的買入評級,並將目標股價上調至44美元
Benzinga ·  11/07 18:48  · 評級/大行評級

Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $37 to $44.

Needham分析師Mike Matson維持對Veracyte(納斯達克:VCYT)的買入評級,並將目標股價從37美元上調至44美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論